NanoViricides, Inc. (NYSE:NNVC) (the “Company”), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021 with the Securities and Exchange Commission (SEC) on Tuesday, October 12, 2021. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/0001379006/000110465921125343/tm2124471d1_10k.htm)
RBC Capital Downgrades Medtronic to Sector Perform, Lowers Price Target to $89
RBC Capital analyst Shagun Singh downgrades Medtronic (NYSE:MDT) from Outperform to Sector Perform and lowers the price target from $102 to $89.
